Genome Engineering is a process in which DNA is inserted, deleted or modified in the genome living organism. This therapy involves the transfer of genes in cultured cells and then introducing in the patient while some are directly introduced. The market is valued at $3.20 billion in 2017 and is estimated to reach $6.30 billion by the end of 2024, growing with a CAGR of 14.8%. The factors such as high prevalence of infectious diseases and cancer, growth in a number of genomics projects and rising government funding and technological advancements coupled with genetically modified crops are driving the market growth. Whereas, the factors such as lack of trained professionals and the high cost of genomic equipment, security issues related to large volumes of data are restraining the market growth. The market has a significant opportunity like usage of genome editing in personalised medicine which is profiting the market growth.
Research Study Objectives:
- Define, estimate, and forecast the Genome Editing/ Genome Engineering market statistics by technology, application and end-user, and regions concerning the individual growth drivers, market trends and their contribution toward the Genome Editing/ Genome Engineering market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints &Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Genome Editing/ Genome Engineering Market Analysis
- Analysis and conclusions on the future Genome Editing/ Genome Engineering market outlook.
Top-down and bottom-up approaches are used to validate the Genome Editing/ Genome Engineering Market Size and are used to estimate the size of other dependent submarkets. Key players
in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Genome Editing/ Genome Engineering Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Genome Editing/ Genome Engineering market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Genome Editing / Genome Engineering market segmentation is as follows:
By Technology
- Talen
- Antisense
- ZFN
- Others
By Application
- Cell Line Engineering
- Genome Editing / Genome Engineering
- Plant Genome Editing / Genome Engineering
- Animal Genome Editing / Genome Engineering
- Others
By End-User
- Academic & Government Research Institutes
- Biotechnology & Pharmaceutical Companies
- Contract Research Organizations
Geographical Analysis:
Genome Editing / Genome Engineering Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan,
South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Genome Editing/ Genome Engineering Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Genome Editing/ Genome Engineering Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Genome Editing/ Genome Engineering market players, such as
- Sangamo Biosciences
- Integrated DNA Technologies
- Thermo Fisher Scientific
- Genscript Corporation
- Horizon Discovery Group
- Along with these companies, many other companies are considered in the report while analysing the Global Genome Editing/ Genome Engineering competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
